1. Home
  2. TXMD vs SINT Comparison

TXMD vs SINT Comparison

Compare TXMD & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXMD
  • SINT
  • Stock Information
  • Founded
  • TXMD 2008
  • SINT 1996
  • Country
  • TXMD United States
  • SINT United States
  • Employees
  • TXMD N/A
  • SINT N/A
  • Industry
  • TXMD Biotechnology: Pharmaceutical Preparations
  • SINT Medical/Dental Instruments
  • Sector
  • TXMD Health Care
  • SINT Health Care
  • Exchange
  • TXMD Nasdaq
  • SINT Nasdaq
  • Market Cap
  • TXMD 12.3M
  • SINT 11.6M
  • IPO Year
  • TXMD N/A
  • SINT 2014
  • Fundamental
  • Price
  • TXMD N/A
  • SINT $4.52
  • Analyst Decision
  • TXMD
  • SINT Strong Buy
  • Analyst Count
  • TXMD 0
  • SINT 1
  • Target Price
  • TXMD N/A
  • SINT $25.00
  • AVG Volume (30 Days)
  • TXMD 16.0K
  • SINT 118.4K
  • Earning Date
  • TXMD 11-11-2025
  • SINT 11-11-2025
  • Dividend Yield
  • TXMD N/A
  • SINT N/A
  • EPS Growth
  • TXMD N/A
  • SINT N/A
  • EPS
  • TXMD N/A
  • SINT N/A
  • Revenue
  • TXMD $2,559,000.00
  • SINT $1,861,000.00
  • Revenue This Year
  • TXMD $427.09
  • SINT N/A
  • Revenue Next Year
  • TXMD N/A
  • SINT $87.50
  • P/E Ratio
  • TXMD N/A
  • SINT N/A
  • Revenue Growth
  • TXMD 156.93
  • SINT N/A
  • 52 Week Low
  • TXMD $0.70
  • SINT $1.71
  • 52 Week High
  • TXMD $2.44
  • SINT $8.60
  • Technical
  • Relative Strength Index (RSI)
  • TXMD 44.55
  • SINT 51.41
  • Support Level
  • TXMD $0.99
  • SINT $3.72
  • Resistance Level
  • TXMD $1.11
  • SINT $4.23
  • Average True Range (ATR)
  • TXMD 0.03
  • SINT 0.39
  • MACD
  • TXMD 0.00
  • SINT -0.09
  • Stochastic Oscillator
  • TXMD 57.85
  • SINT 34.33

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: